
On 12 Nov 2026 Intuitive Surgical closed at $439.89, -22.3% this year; market cap $154.67bn, P/E 52.3.
Health Care · Health Care Equipment · NASDAQ · United States
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Market cap | $154.67bn |
| P/E (trailing) | 52.3 |
| EPS (TTM) | $8.41 |
| Beta | 1.44 |
| Dividend | $0.00 |
| Dividend yield | 0.00% |
| Ex-dividend date | — |
| Latest report | 20 Oct 2026 |
| Next earnings | 19 Jan 2027 |
| YTD | -22.3% |
| 1Y | -23.2% |
| 3Y | +15.9% |
| 5Y | +4.4% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $10.06bn | $2.86bn | $2.49bn |
| 2024 | $8.35bn | $2.32bn | $1.30bn |
| 2023 | $7.12bn | $1.80bn | $749.60m |
| 2022 | $6.22bn | $1.32bn | $958.40m |
| 2021 | $5.71bn | $1.70bn | $1.74bn |
Base value $404.89 (-8.0% vs price); 0 of 1 methods above the price. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.